(Q54386714)

29 May 2018

title

Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers. (English)

1 reference

29 May 2018

1

Dirk Rades

1 reference

29 May 2018

author name string

Daniel Seidl

2

1 reference

29 May 2018

Stefan Janssen

3

1 reference

29 May 2018

Primoz Strojan

4

1 reference

29 May 2018

Katarina Karner

5

1 reference

29 May 2018

Amira Bajrovic

6

1 reference

29 May 2018

Samer G Hakim

7

1 reference

29 May 2018

Barbara Wollenberg

8

1 reference

29 May 2018

Steven E Schild

9

1 reference

29 May 2018

publication date

29 September 2016

1 reference

29 May 2018

European Archives of Oto-Rhino-Laryngology

published in

1 reference

29 May 2018

volume

274

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

1021-1027

1 reference

29 May 2018

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-016-4326-5

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

21 January 2018

1 reference

12 December 2020

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

12 December 2020

Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer

1 reference

12 December 2020

Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy

1 reference

12 December 2020

Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: a retrospective comparison from New Cross Hospital, Wolverhampton, UK

1 reference

12 December 2020

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

1 reference

12 December 2020

10.1007/S00405-016-4326-5

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018